← Back to home

INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN

Clinical trials for INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN explained in plain language.

Never miss a new study

Get alerted when new INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN trials appear

Sign up with your email to follow new studies for INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New eye treatment shows promise for common vision loss condition

Symptom relief Completed

This study tested a treatment called transcleral lutein iontophoresis in 30 people with intermediate age-related macular degeneration and a specific type of eye deposit. The treatment uses a mild electrical current to deliver lutein, a nutrient, into the eye. Researchers looked a…

Matched conditions: INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN

Sponsor: Mario Damiano Toro • Aim: Symptom relief

Last updated May 06, 2026 16:15 UTC

INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN

Get alerted when new INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN trials appear

New eye treatment shows promise for common vision loss condition